Amikacin for Ventilator-Associated Pneumonia (AMIKINHAL trial)

You don’t hear much about ventilator-associated pneumonia (VAP) anymore. It used to be highly prevalent in U.S. ICUs, and a popular research focus for academics, generating a steady stream of papers. Then, in 2009, the condition disappeared completely.

Just kidding! In 2008, the U.S. government proposed adding VAP to its “hospital-acquired conditions” li…